ZyVersa Therapeutics News

Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements

TipRanksMar 26 18:25

ZyVersa Therapeutics Analyst Ratings

BenzingaMar 26 18:20

Zyversa Therapeutics' 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity

TipRanksMar 26 14:05

ZyVersa Therapeutics Analyst Ratings

BenzingaMar 12 20:25

HC Wainwright & Co. Maintains Buy on ZyVersa Therapeutics, Lowers Price Target to $12

BenzingaMar 12 20:25

Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)

TipRanksMar 12 18:35

HC Wainwright & Co. Reiterates Buy on ZyVersa Therapeutics, Maintains $24 Price Target

BenzingaFeb 29 22:09

Buy Rating Affirmed for ZyVersa Therapeutics Amid Promising Inflammatory and Metabolic Syndrome Treatments

TipRanksFeb 29 19:46

HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5

BenzingaSep 8, 2023 18:59

ZyVersa Therapeutics Analyst Ratings

BenzingaSep 8, 2023 18:58

Analysts Offer Insights on Healthcare Companies: ZyVersa Therapeutics (ZVSA), Halozyme (HALO) and Nurix Therapeutics (NRIX)

TipRanksSep 8, 2023 18:20